Cargando…
Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study
BACKGROUND: In patients with nonvalvular atrial fibrillation (NVAF), embolic stroke is thought to be associated with left atrial appendage (LAA) thrombi. The WATCHMAN LAA Occlusion Device has been shown to be noninferior to conventional oral anticoagulation with warfarin for stroke prevention in pat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324380/ https://www.ncbi.nlm.nih.gov/pubmed/28218217 http://dx.doi.org/10.4103/0366-6999.199832 |
_version_ | 1782510217250996224 |
---|---|
author | Huang, Wei-Ping Zhang, Yong-Hua He, Lei Su, Xi Yang, Xin-Wei Guo, Zai-Xiong |
author_facet | Huang, Wei-Ping Zhang, Yong-Hua He, Lei Su, Xi Yang, Xin-Wei Guo, Zai-Xiong |
author_sort | Huang, Wei-Ping |
collection | PubMed |
description | BACKGROUND: In patients with nonvalvular atrial fibrillation (NVAF), embolic stroke is thought to be associated with left atrial appendage (LAA) thrombi. The WATCHMAN LAA Occlusion Device has been shown to be noninferior to conventional oral anticoagulation with warfarin for stroke prevention in patients with NVAF. This study aimed to evaluate the procedural feasibility, safety and 12-month outcomes of the WATCHMAN LAA Occlusion Device in NVAF patients with high risk for stroke in China. METHODS: The clinical data of 106 NVAF patients, who were consecutively underwent LAA closure with the WATCHMAN Device between April 2014 and May 2015, were collected. Patients were followed up at 1, 3, 6, and 12 months after discharge. A transesophageal echocardiograph was performed at 45 days after implantation and repeated in case of an unexpected event during the follow-up period. RESULTS: This study included 106 NVAF patients with a mean age of 64.2 ± 8.6 years (ranging from 50 to 88 years), and the mean CHA(2)DS(2)-VASc score of all patients was 3.6 ± 1.6 (ranging from 2 to 9). Among those 106 NVAF patients, 100 (94.3%) patients were implanted with the device successfully. The procedural success rate was 94.3% (100/106), and the occlusion rate was 100.0% (100/100). There were one tamponade, one ischemic stroke, and eight minor pericardial effusions during hospitalization. During 12-month follow-up period, two patients developed a thrombus layer on the device that resolved with additional anticoagulation: one with visible device-thrombus experienced transient ischemic stroke, and one had a hemorrhagic stroke. There were no deaths in this study. The overall survival rate was 100.0%, and nonmajor adverse event rate was 95.0% (95/100). In this study, the expected annual rate of ischemic stroke risk in these patients according to the CHA(2)DS(2)-VASc score was 4.0%, while the observed ischemic stroke rate was 2.0% per year. CONCLUSIONS: LAA closure with the WATCHMAN Device was feasible, efficient, and safe for NVAF to prevent the accidence of stroke in Chinese patients. During the 12-month follow-up period, the observed ischemic stroke rate (2.0% per year) in our study was lower than the predicted annual stroke risk (4.0%) using the CHA(2)DS(2)-VASc score. |
format | Online Article Text |
id | pubmed-5324380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-53243802017-03-01 Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study Huang, Wei-Ping Zhang, Yong-Hua He, Lei Su, Xi Yang, Xin-Wei Guo, Zai-Xiong Chin Med J (Engl) Original Article BACKGROUND: In patients with nonvalvular atrial fibrillation (NVAF), embolic stroke is thought to be associated with left atrial appendage (LAA) thrombi. The WATCHMAN LAA Occlusion Device has been shown to be noninferior to conventional oral anticoagulation with warfarin for stroke prevention in patients with NVAF. This study aimed to evaluate the procedural feasibility, safety and 12-month outcomes of the WATCHMAN LAA Occlusion Device in NVAF patients with high risk for stroke in China. METHODS: The clinical data of 106 NVAF patients, who were consecutively underwent LAA closure with the WATCHMAN Device between April 2014 and May 2015, were collected. Patients were followed up at 1, 3, 6, and 12 months after discharge. A transesophageal echocardiograph was performed at 45 days after implantation and repeated in case of an unexpected event during the follow-up period. RESULTS: This study included 106 NVAF patients with a mean age of 64.2 ± 8.6 years (ranging from 50 to 88 years), and the mean CHA(2)DS(2)-VASc score of all patients was 3.6 ± 1.6 (ranging from 2 to 9). Among those 106 NVAF patients, 100 (94.3%) patients were implanted with the device successfully. The procedural success rate was 94.3% (100/106), and the occlusion rate was 100.0% (100/100). There were one tamponade, one ischemic stroke, and eight minor pericardial effusions during hospitalization. During 12-month follow-up period, two patients developed a thrombus layer on the device that resolved with additional anticoagulation: one with visible device-thrombus experienced transient ischemic stroke, and one had a hemorrhagic stroke. There were no deaths in this study. The overall survival rate was 100.0%, and nonmajor adverse event rate was 95.0% (95/100). In this study, the expected annual rate of ischemic stroke risk in these patients according to the CHA(2)DS(2)-VASc score was 4.0%, while the observed ischemic stroke rate was 2.0% per year. CONCLUSIONS: LAA closure with the WATCHMAN Device was feasible, efficient, and safe for NVAF to prevent the accidence of stroke in Chinese patients. During the 12-month follow-up period, the observed ischemic stroke rate (2.0% per year) in our study was lower than the predicted annual stroke risk (4.0%) using the CHA(2)DS(2)-VASc score. Medknow Publications & Media Pvt Ltd 2017-02-20 /pmc/articles/PMC5324380/ /pubmed/28218217 http://dx.doi.org/10.4103/0366-6999.199832 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Huang, Wei-Ping Zhang, Yong-Hua He, Lei Su, Xi Yang, Xin-Wei Guo, Zai-Xiong Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study |
title | Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study |
title_full | Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study |
title_fullStr | Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study |
title_full_unstemmed | Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study |
title_short | Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study |
title_sort | efficacy and safety of the watchman left atrial appendage system for stroke prevention in chinese patients with nonvalvular atrial fibrillation: a single-center, prospective, observational study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324380/ https://www.ncbi.nlm.nih.gov/pubmed/28218217 http://dx.doi.org/10.4103/0366-6999.199832 |
work_keys_str_mv | AT huangweiping efficacyandsafetyofthewatchmanleftatrialappendagesystemforstrokepreventioninchinesepatientswithnonvalvularatrialfibrillationasinglecenterprospectiveobservationalstudy AT zhangyonghua efficacyandsafetyofthewatchmanleftatrialappendagesystemforstrokepreventioninchinesepatientswithnonvalvularatrialfibrillationasinglecenterprospectiveobservationalstudy AT helei efficacyandsafetyofthewatchmanleftatrialappendagesystemforstrokepreventioninchinesepatientswithnonvalvularatrialfibrillationasinglecenterprospectiveobservationalstudy AT suxi efficacyandsafetyofthewatchmanleftatrialappendagesystemforstrokepreventioninchinesepatientswithnonvalvularatrialfibrillationasinglecenterprospectiveobservationalstudy AT yangxinwei efficacyandsafetyofthewatchmanleftatrialappendagesystemforstrokepreventioninchinesepatientswithnonvalvularatrialfibrillationasinglecenterprospectiveobservationalstudy AT guozaixiong efficacyandsafetyofthewatchmanleftatrialappendagesystemforstrokepreventioninchinesepatientswithnonvalvularatrialfibrillationasinglecenterprospectiveobservationalstudy |